| ICMR Approved | Yes |
| Brand Name | COVIRAT |
| Brand | COVIRAT |
| Test Method | (SARS-CoV-2) RT-PCR |
| Country of Origin | Made in India |
CoviRAT is an invitro, rapid, qualitative immunoassay for the detection of nucleocapsid protein antigens expressed by the SARSCoV2 virus present in human nasopharyngeal swab specimen. It is to be used for screening or to aid in the diagnosis of COVID19 and takes 1530 minutes for producing test result. Rapid antigen tests are known to be sensitive enough to detect clinical cases, i.e. presymptomatic and early symptomatic cases (up to five days from symptom onset; or low RTPCR cycle threshold (Ct) value <30), which likely account for a significant proportion of transmissions. The use of sensitive and specific rapid antigen test is appropriate in high prevalence areas as well as in low prevalence areas to identify the infectious positive cases. Rapid antigen tests can help reduce further transmission through early identification of positive cases, enabling a faster contact tracing. Double Antibody Sandwich Assay. Monoclonal antibodies used in both capture and tracer part. Nasopharyngeal specimen can be used. Rapid Antigen Detection Test. Sterile Breakable nasopharyngeal swabs. Sensitivity 96.3%* Specificity 100% Detects nucleocapsid protein antigens expressed by SARSCoV2 virus. Ensures specific detection and timely isolation of the infected person.
